Fresenius SE & Co. KGaA (FSNUF)
OTCMKTS · Delayed Price · Currency is USD
55.90
0.00 (0.00%)
At close: Dec 12, 2025
Fresenius SE & Co. KGaA Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of $32.34 billion as of December 24, 2025. Its market cap has increased by 57.72% in one year.
Market Cap
32.34B
Enterprise Value
46.26B
Revenue
26.33B
Ranking
n/a
PE Ratio
24.12
Stock Price
$55.90
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 2.17B to 32.34B, an increase of 1,390.36%. That is a compound annual growth rate of 9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 32.34B | 65.00% |
| Dec 30, 2024 | 19.60B | 12.16% |
| Dec 29, 2023 | 17.48B | 10.60% |
| Dec 30, 2022 | 15.80B | -29.41% |
| Dec 30, 2021 | 22.38B | -13.65% |
| Dec 30, 2020 | 25.92B | -17.36% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 730.42M |
| Elite Pharmaceuticals | 515.58M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 390.29M |
| CytoDyn | 359.24M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |